Boone Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Boone Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.7M	Sell	415,641 -5,595	-1%	-$562K	11.38%	2
2026 Q1	$38.9M	Hold	421,236	–	–	11.92%	1
2025 Q4	$33.3M	Sell	421,236 -114,496	-21%	-$8.22M	10.44%	2
2025 Q3	$39.3M	Sell	535,732 -105,716	-16%	-$6.72M	12.88%	2
2025 Q2	$32.6M	Buy	641,448 +38,130	+6%	+$1.7M	14%	2
2025 Q1	$27.2M	Buy	603,318 +21,475	+4%	+$1.01M	9.25%	3
2024 Q4	$24.1M	Buy	581,843 +38,000	+7%	+$1.58M	8.12%	4
2024 Q3	$21.2M	Buy	543,843 +20,164	+4%	+$804K	5.5%	7
2024 Q2	$17.9M	Buy	523,679 +71,781	+16%	+$1.88M	4.67%	9
2024 Q1	$11.4M	Sell	451,898 -38,241	-8%	-$1.05M	2.3%	19
2023 Q4	$14.5M	Buy	490,139 +100,348	+26%	+$3.04M	3.38%	16
2023 Q3	$12.3M	Buy	+389,791	New	+$10.7M	3.89%	12

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boone Capital Management's MIRM Position: Q2 2026 in Review

Boone Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 1.3% in Q2 2026, selling an estimated $562K and leaving 415,641 shares worth $48.7M. The position accounts for 11.38% of the portfolio, ranked #2.

Boone Capital Management first reported a position in MIRM in Q3 2023 and has held it in 12 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Boone Capital Management held 415,641 shares of Mirum Pharmaceuticals worth $48.7M as of Q2 2026.
Boone Capital Management sold 5,595 Mirum Pharmaceuticals shares in Q2 2026, an estimated $562K.
Mirum Pharmaceuticals made up 11.38% of Boone Capital Management's portfolio in Q2 2026, its #2 holding.
Boone Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Boone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.